Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes

Journal of Molecular Cell Biology

Volumn 4, Issue 1, 2012, Pages 38-47

  Li, Cheng Rui ^a   Baaten, Bas J G ^a   Bradley, Linda M ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

adaptive regulatory T cells; autoimmunity; immunotherapy; type 1 diabetes

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE REGULATORY T LYMPHOCYTE; AUTOIMMUNITY; CELL FUNCTION; CELL LINE; CELL MATURATION; CELL THERAPY; DISEASE COURSE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INSULIN-SECRETING CELLS; INTEGRIN BETA CHAINS; INTERLEUKIN-2; MICE; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863051225     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjr040     Document Type: Review

References (125)

1. Akerblom, H.K., Virtanen, S.M., Ilonen, J., et al. (2005). Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: A pilot study. Diabetologia 48, 829-837. (Pubitemid 40767974)
2. Ansel, K.M., Lee, D.U., and Rao, A. (2003). An epigenetic view of helper T cell differentiation. Nat. Immunol. 4, 616-623. (Pubitemid 36880738)
3. Atkinson, M.A. (2005). ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: Why can't we prevent or reverse this disease? Diabetes 54, 1253-1263. (Pubitemid 40586652)
4. Bach, J.F. (2002). The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-920.
5. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603-616. (Pubitemid 34461505)
6. Barrett, J.C., Clayton, D.G., Concannon, P., et al. (2009). Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703-707.
7. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338-8347. (Pubitemid 44893795)
8. + T cells. J. Exp. Med. 166, 823-832. (Pubitemid 18024228)
9. Bluestone, J.A., and Abbas, A.K. (2003). Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257. (Pubitemid 37323210)
10. + regulatory T cells. J. Immunol. 179, 744-747.
11. + regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J. Immunol. 183, 2232-2241.
12. Bresson, D., Togher, L., Rodrigo, E., et al. (2006). Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest. 116, 1371-1381.
13. Bruder, D., Westendorf, A.M., Hansen, W., et al. (2005). On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54, 3395-3401. (Pubitemid 43334328)
14. + T-cells in type 1 diabetes. Diabetes 54, 1407-1414. (Pubitemid 40586671)
15. + regulatory T-cells in type 1 diabetes. Diabetes 56, 604-612. (Pubitemid 46348451)
16. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886. (Pubitemid 38032120)
17. Cheng, G., Yu, A., andMalek, T.R. (2011). T-cell tolerance and themulti-functional role of IL-2R signaling in T-regulatory cells. Immunol. Rev. 241, 63-76.
18. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42, 44-55. (Pubitemid 23013794)
19. Cobbold, S.P., Nolan, K.F., Graca, L., et al. (2003). Regulatory T cells and dendritic cells in transplantation tolerance: Molecular markers and mechanisms. Immunol. Rev. 196, 109-124. (Pubitemid 37468107)
20. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764. (Pubitemid 47236314)
21. Dai, Y.D., Carayanniotis, G., and Sercarz, E. (2005). Antigen processing by autoreactive B cells promotes determinant spreading. Cell. Mol. Immunol. 2, 169-175.
22. + T regulatory cells. J. Immunol. 178, 4022-4026. (Pubitemid 46492349)
23. Dendrou, C.A., and Wicker, L.S. (2008). The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J. Clin. Immunol. 28, 685-696.
24. + T-cell clones specific for pancreatic islet autoantigens. J. Autoimmun. 36, 47-55.
25. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153. (Pubitemid 38542009)
26. + regulatory T cells: Differentiation, specification, subphenotypes. Nat. Immunol. 10, 689-695.
27. Feuerer, M., Hill, J.A., Kretschmer, K., et al. (2010). Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl Acad. Sci. USA 107, 5919-5924.
28. Floess, S., Freyer, J., Siewert, C., et al. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38.
29. + regulatory T cells. Eur. J. Immunol. 41, 1242-1248.
30. Gepts, W., and Lecompte, P.M. (1981). The pancreatic islets in diabetes. Am. J. Med. 70, 105-115.
31. Godebu, E., Summers-Torres, D., Lin, M.M., et al. (2008). Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells. J. Immunol. 181, 1798-1805.
32. Hanninen, A., Taylor, C., Streeter, P.R., et al. (1993). Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J. Clin. Invest. 92, 2509-2515. (Pubitemid 23333561)
33. Harbertson, J., Biederman, E., Bennett, K.E., et al. (2002). Withdrawal of stimulation may initiate the transition of effector to memory CD4 cells. J. Immunol. 168, 1095-1102. (Pubitemid 34094473)
34. Herold, K.C., Hagopian, W., Auger, J.A., et al. (2002). Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698. (Pubitemid 34547482)
35. Herold, K.C., Gitelman, S.E., Masharani, U., et al. (2005). A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54, 1763-1769. (Pubitemid 40770766)
36. Hiemstra, H.S., Schloot, N.C., van Veelen, P.A., et al. (2001). Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA 98, 3988-3991. (Pubitemid 32249885)
37. Hippen, K.L., Merkel, S.C., Schirm, D.K., et al. (2011a). Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am. J. Transplant. 11, 1148-1157.
38. Hippen, K.L., Riley, J.L., June, C.H., et al. (2011b). Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 23, 462-468.
39. Horwitz, M.S., Bradley, L.M., et al. (1998). Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat. Med. 4, 781-785. (Pubitemid 28331018)
40. + Treg. Eur. J. Immunol. 38, 912-915.
41. + T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2, 705-710. (Pubitemid 32747159)
42. Josefowicz, S.Z., and Rudensky, A. (2009). Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616-625.
43. Kassem, S.A., Ariel, I., Thornton, P.S., et al. (2000). Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49, 1325-1333. (Pubitemid 30624233)
44. Keenan, H.A., Sun, J.K., Levine, J., et al. (2010). Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59, 2846-2853.
45. + T cells in pancreatic lymph nodes. Immunotherapy 1, 539-547.
46. Kilshaw, P.J., and Higgins, J.M. (2002). Alpha E: No more rejection? J. Exp. Med. 196, 873-875.
47. Kondrack, R.M., Harbertson, J., Tan, J.T., et al. (2003). Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198, 1797-1806. (Pubitemid 38032113)
48. Kretschmer, K., Heng, T.S., and von Boehmer, H. (2006). De novo production of antigen-specific suppressor cells in vivo. Nat. Protoc. 1, 653-661.
49. Kukreja, A., Cost, G., Marker, J., et al. (2002). Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109, 131-140. (Pubitemid 34052549)
50. +CD25 hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin. Exp. Immunol. 154, 353-359.
51. Lennon, G.P., Bettini, M., Burton, A.R., et al. (2009). T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31, 643-653.
52. + adaptive Treg cells that reverse diabetes in NOD mice via integrin-beta7-dependent localization. J. Autoimmun. 37, 217-227.
53. Lim, S.P., Leung, E., and Krissansen, G.W. (1998). The beta7 integrin gene (Itgb-7) promoter is responsive to TGF-beta1: Defining control regions. Immunogenetics 48, 184-195. (Pubitemid 28352184)
54. + T-cells from patients with type 1 diabetes. Diabetes 54, 92-99. (Pubitemid 40105099)
55. Lo, J., Peng, R.H., Barker, T., et al. (2006). Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes. Ann. NY Acad. Sci. 1079, 153-156. (Pubitemid 44968716)
56. + T cells. J. Autoimmun. 30, 293-302.
57. - T cells of healthy and type 1 diabetic subjects. Eur. J. Immunol. 39, 612-620.
58. + regulatory T-cells of type 1 diabetic subjects. Diabetes 59, 407-415.
59. + regulatory T cells generated with IL-2, TGF-beta and retinoic acid. PLoS One 5, e15150.
60. + regulatory T cells. Proc. Natl Acad. Sci. USA 104, 2821-2826. (Pubitemid 46327963)
61. Luo, X., Herold, K.C., and Miller, S.D. (2010). Immunotherapy of type 1 diabetes: Where are we and where should we be going? Immunity 32, 488-499.
62. Maldonado, R.A., and von Andrian, U.H. (2010). How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108, 111-165.
63. McClymont, S.A., Putnam, A.L., Lee, M.R., et al. (2011). Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918-3926.
64. McKinstry, K.K., Golech, S., Lee, W.H., et al. (2007). Rapid default transition of CD4 T cell effectors to functional memory cells. J. Exp. Med. 204, 2199-2211. (Pubitemid 47360879)
65. Merkenschlager, M., and von Boehmer, H. (2010). PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J. Exp. Med. 207, 1347-1350.
66. Miyazaki, A., Hanafusa, T., Yamada, K., et al. (1985). Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: A longitudinal study. Clin. Exp. Immunol. 60, 622-630. (Pubitemid 15021367)
67. Mucida, D., Park, Y., Kim, G., et al. (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260. (Pubitemid 47076203)
68. Murai, M., Turovskaya, O., Kim, G., et al. (2009). Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184.
69. O'Garra, A., Gabrysova, L., and Spits, H. (2011). Quantitative events determine the differentiation and function of helper T cells. Nat. Immunol. 12, 288-294.
70. + regulatory T cells. Eur. J. Immunol. 41, 1249-1255.
71. + regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA 101, 4572-4577. (Pubitemid 38437452)
72. Powell, J.D., and Delgoffe, G.M. (2010). The mammalian target of rapamycin: Linking T cell differentiation, function, and metabolism. Immunity 33, 301-311.
73. +CD25 high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24, 55-62. (Pubitemid 40269495)
74. Qian, X., Wang, K., Wang, X., et al. (2011). Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease. Int. Immunopharmacol. 11, 630-637.
75. Scaglia, L., Cahill, C.J., Finegood, D.T., et al. (1997). Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138, 1736-1741. (Pubitemid 27137129)
76. + regulatory T cells. J. Immunol. 181, 7350-7355.
77. Selvaraj, R.K., and Geiger, T.L. (2007). A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 179, 11 p following 1390.
78. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735. (Pubitemid 40395118)
79. Shevach, E.M., Tran, D.Q., Davidson, T.S., et al. (2008). The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38, 915-917.
80. Shoda, L.K., Young, D.L., Ramanujan, S., et al. (2005). A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23, 115-126. (Pubitemid 41169282)
81. Stadinski, B., Kappler, J., and Eisenbarth, G.S. (2010). Molecular targeting of islet autoantigens. Immunity 32, 446-456.
82. Stene, L.C., and Joner, G. (2003). Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: A large, population-based, case-control study. Am. J. Clin. Nutr. 78, 1128-1134. (Pubitemid 39663453)
83. Sun, C.M., Hall, J.A., Blank, R.B., et al. (2007). Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785. (Pubitemid 47236316)
84. Tang, Q., Adams, J.Y., Penaranda, C., et al. (2008). Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687-697.
85. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467-1477. (Pubitemid 38780402)
86. Todd, J.A. (1991). A protective role of the environment in the development of type 1 diabetes? Diabet. Med. 8, 906-910.
87. Todd, J.A., Walker, N.M., Cooper, J.D., et al. (2007). Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857-864. (Pubitemid 47018195)
88. Tone, Y., Furuuchi, K., Kojima, Y., et al. (2008). Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202.
89. Tonkin, D.R., and Haskins, K. (2009). Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner. Eur. J. Immunol. 39, 1313-1322.
90. Tonkin, D.R., He, J., Barbour, G., et al. (2008). Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J. Immunol. 181, 4516-4522.
91. - T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110, 2983-2990. (Pubitemid 350006952)
92. Turley, S., Poirot, L., Hattori, M., et al. (2003). Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198, 1527-1537. (Pubitemid 37467167)
93. + regulatory T cell induction and expansion. J. Immunol. 183, 4895-4903.
94. Vehik, K., and Dabelea, D. (2011). The changing epidemiology of type 1 diabetes: Why is it going through the roof? Diabetes Metab. Res. Rev. 27, 3-13.
95. Vendrame, F., Pileggi, A., Laughlin, E., et al. (2010). Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59, 947-957.
96. Vignali, D.A., Collison, L.W., and Workman, C.J. (2008). How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532.
97. Waldron-Lynch, F., and Herold, K.C. (2011). Immunomodulatory therapy to preserve pancreatic beta-cell function in type 1 diabetes. Nat. Rev. Drug Discov. 10, 439-452.
98. - T cells. J. Clin. Invest. 112, 1437-1443. (Pubitemid 38057697)
99. - cells. Proc. Natl Acad. Sci. USA 102, 4103-4108. (Pubitemid 40388562)
100. + T cells. Eur. J. Immunol. 37, 129-138. (Pubitemid 46128793)
101. Weber, S.E., Harbertson, J., Godebu, E., et al. (2006). Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 176, 4730-4739.
102. Weinberg, A.D., Whitham, R., Swain, S.L., et al. (1992). Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J. Immunol. 148, 2109-2117.
103. Weiner, H.L. (2001). Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182, 207-214. (Pubitemid 33070220)
104. Wen, L., Peng, J., Li, Z., and Wong, F.S. (2004). The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol. 172, 3173-3180. (Pubitemid 38263708)
105. Wen, L., Ley, R.E., Volchkov, P.Y., et al. (2008). Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109-1113.
106. Wherrett, D.K., Bundy, B., Becker, D.J., et al. (2011). Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: A randomised double-blind trial. Lancet 378, 319-327.
107. Wicker, L.S., Clark, J., Fraser, H.I., et al. (2005). Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25(Suppl), 29-33. (Pubitemid 41728041)
108. Willcox, A., Richardson, S.J., Bone, A.J., et al. (2009). Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173-181.
109. Wing, K., and Sakaguchi, S. (2010). Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13.
110. Wong, J., Mathis, D., and Benoist, C. (2007). TCR-based lineage tracing: No evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. 204, 2039-2045. (Pubitemid 47360866)
111. Wong, W.F., Kohu, K., Chiba, T., et al. (2011). Interplay of transcription factors in T-cell differentiation and function: The role of Runx. Immunology 132, 157-164.
112. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181, 2277-2284.
113. Yang, X.D., Michie, S.A., Tisch, R., et al. (1994). A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 91, 12604-12608.
114. Yang, X.D., Sytwu, H.K., McDevitt, H.O., et al. (1997). Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 46, 1542-1547. (Pubitemid 27411227)
115. You, S., Leforban, B., Garcia, C., et al. (2007). Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl Acad. Sci. USA 104, 6335-6340. (Pubitemid 47186095)
116. Zaccone, P., Burton, O.T., Gibbs, S., et al. (2010). Immune modulation by Schistosoma mansoni antigens in NOD mice: Effects on both innate and adaptive immune systems. J. Biomed. Biotechnol. 2010, 795210.
117. - precursors. J. Immunol. 169, 4183-4189. (Pubitemid 35178188)
118. - cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10. J. Immunol. 172, 5213-5221. (Pubitemid 38542018)
119. + regulatory T cells and for expansion of these cells. J. Immunol. 178, 2018-2027. (Pubitemid 46233398)
120. + regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 180, 7112-7116.
121. Zheng, Y., Chaudhry, A., Kas, A., et al. (2009). Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 458, 351-356.
122. Zhou, X., Bailey-Bucktrout, S.L., Jeker, L.T., et al. (2009). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
123. Zhou, X., Kong, N., Wang, J., et al. (2010). Cutting edge: All-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J. Immunol. 185, 2675-2679.
124. Ziegler, S.F. (2007). FOXP3: Not just for regulatory T cells anymore. Eur. J. Immunol. 37, 21-23. (Pubitemid 46128782)
125. Ziegler, A.G., Pflueger, M., Winkler, C., et al. (2011). Accelerated progression from islet autoimmunity to diabetes is ausing the escalating incidence of type 1 diabetes in young children. J. Autoimmun. 37, 3-7.